No Nonsense: David Liu Lauds Progress in Disease-Agnostic Gene Editing at ESGCT

Coverage, in order

1. 12d ago
   
   first GEN Genetic Engineering News indie

   No Nonsense: David Liu Lauds Progress in Disease-Agnostic Gene Editing at ESGCT

   HAMBURG —The distinguished researcher who had the dubious honor of speaking before David Liu, PhD, in a plenary session at the European Society of Gene & Cell Therapy (ESGCT)—2018 Kavli Award winner Virginijus Siksnys, PhD—opened his talk with a bashful admission: “I’m just the warm up for David,”…

2. 10d ago
   
   GEN Genetic Engineering News indie

   StockWatch: Gene Editing Shares Jump on ESGCT Data, FDA Draft Guidance

   Shares of gene editing therapy companies mostly surged by double digits this past week on two growth catalysts. One catalyst was expected: The European Society of Gene and Cell Therapy’s 33rd ESGCT Annual Congress , which finished Friday in Hamburg, Germany, brought forth the usual flurry of data…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.